Cognitive profiles of healthy siblings of schizophrenia patients: Application of the cognitive domains of the MATRICS consensus battery

References

• Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control 1974; 19: 716–723
   Web of Science ®Google Scholar
• Appels MC, Sitskoorn MM, Westers P, Lems E, Kahn RS. Cognitive dysfunctions in parents of schizophrenic patients parallel the deficits found in patients. Schizophr Res 2003; 63: 285–293
   PubMedGoogle Scholar
• Asarnow RF, Nuechterlein KH. Directions for Use of the UCLA Span of Apprehension Program, Version 5.3 for Arrays 3 and 12 Letters, on IBM AT and Fully Compatible Microcomputers. UCLA Department of Psychiatry and Biobehavioral Sciences, Los Angeles, CA 1994
   Google Scholar
• Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 2002; 159: 1018–1028
   PubMed Web of Science ®Google Scholar
• Bredgaard R, Glenthoj BY. Information processing and attentional dysfunctions as vulnerability indicators in schizophrenia spectrum disorders. World J Biol Psychiatry 2000; 1: 5–15
   PubMedGoogle Scholar
• Cannon TD, Zorrilla LE, Shtasel D, Gur RE, Gur RC, Marco EJ, et al. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch Gen Psychiatry 1994; 51: 651–661
   PubMed Web of Science ®Google Scholar
• Cannon TD, Huttunen MO, Lonnqvist J, Tuulio-Henriksson A, Pirkola T, Glahn D, et al. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am J Hum Genet 2000; 67: 369–382
   PubMed Web of Science ®Google Scholar
• Cannon TD, Gasperoni TL, van Erp TG, Rosso IM. Quantitative neural indicators of liability to schizophrenia: implications for molecular genetic studies. Am J Med Genet 2001; 105: 16–19
   PubMed Web of Science ®Google Scholar
• Chen YL, Chen YH, Lieh-Mak F. Semantic verbal fluency deficit as a familial trait marker in schizophrenia. Psychiatry Res 2000; 95: 133–148
   PubMed Web of Science ®Google Scholar
• Davalos DB, Compagnon N, Heinlein S, Ross RG. Neuropsychological deficits in children associated with increased familial risk for schizophrenia. Schizophr Res 2004; 67: 123–130
   PubMed Web of Science ®Google Scholar
• Dollfus S, Lombardo C, Benali K, Halbecq I, Abadie P, Marie RM, et al. Executive/attentional cognitive functions in schizophrenic patients and their parents: a preliminary study. Schizophr Res 2002; 53: 93–99
   PubMed Web of Science ®Google Scholar
• Egan MF, Goldberg TE, Gscheidle T, Weirich M, Rawlings R, Hyde TM, et al. Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry 2001; 50: 98–107
   PubMed Web of Science ®Google Scholar
• Erlenmeyer-Kimling L. Early neurobehavioral deficits as phenotypic indicators of the schizophrenia genotype and predictors of later psychosis. Am J Med Genet 2001; 105: 23–24
   PubMed Web of Science ®Google Scholar
• Faraone SV, Seidman LJ, Kremen WS, Toomey R, Pepple JR, Tsuang MT. Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. Biol Psychiatry 2000; 48: 120–126
   PubMed Web of Science ®Google Scholar
• Gasperoni TL, Ekelund J, Huttunen M, Palmer CG, Tuulio-Henriksson A, Lonnqvist J, et al. Genetic linkage and association between chromosome 1q and working memory function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2003; 116: 8–16
   Web of Science ®Google Scholar
• Genderson MR, Dickinson D, Diaz-Asper CM, Egan MF, Weinberger DR, Goldberg TE. Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls. Schizophr Res 2007; 94: 231–239
   PubMedGoogle Scholar
• Goldberg TE, Torrey EF, Gold JM, Bigelow LB, Ragland RD, Taylor E, et al. Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder. Schizophr Res 1995; 17: 77–84
   PubMed Web of Science ®Google Scholar
• Golimbet V, Gritsenko I, Alfimova M, Lebedeva I, Lezheiko T, Abramova L, et al. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. World J Biol Psychiatry 2006; 7: 238–245
   PubMed Web of Science ®Google Scholar
• Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636–645
   PubMed Web of Science ®Google Scholar
• Green MF, Nuechterlein KH. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res 2004; 72: 1–3
   PubMed Web of Science ®Google Scholar
• Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry 2004; 56: 301–307
   PubMed Web of Science ®Google Scholar
• Groom MJ, Jackson GM, Calton TG, Andrews HK, Bates AT, Liddle PF, et al. Cognitive deficits in early-onset schizophrenia spectrum patients and their non-psychotic siblings: a comparison with ADHD. Schizophr Res 2008; 99: 85–95
   PubMed Web of Science ®Google Scholar
• Harris JG, Adler LE, Young DA, Cullum CM, Rilling LM, Cicerello A, et al. Neuropsychological dysfunction in parents of schizophrenics. Schizophr Res 1996; 20: 253–260
   PubMedGoogle Scholar
• Hoff AL, Svetina C, Maurizio AM, Crow TJ, Spokes K, DeLisi LE. Familial cognitive deficits in schizophrenia. Am J Med Genet Part B. Neuropsychiatr Genet 2005; 133: 43–49
   Web of Science ®Google Scholar
• Johnson JK, Tuulio-Henriksson A, Pirkola T, Huttunen MO, Lonnqvist J, Kaprio J, et al. Do schizotypal symptoms mediate the relationship between genetic risk for schizophrenia and impaired neuropsychological performance in co-twins of schizophrenic patients?. Biol Psychiatry 2003; 54: 1200–1204
   PubMed Web of Science ®Google Scholar
• Joo EJ, Joo YH, Hong JP, Hwang S, Maeng SJ, Han JH, et al. Korean version of the diagnostic interview for genetic studies: Validity and reliability. Compr Psychiatry 2004; 45: 225–229
   PubMed Web of Science ®Google Scholar
• Kang Y, Chin J, Na D, Lee J, Park J. A normative study of the Korean Version of Controlled Oral Word Association Test (COWAT) in the elderly. Kor J Clin Psychol 2000; 19: 385–392
   Google Scholar
• Keefe RS, Silverman JM, Roitman SE, Harvey PD, Duncan MA, Alroy D, et al. Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. Psychiatry Res 1994; 53: 1–12
   PubMed Web of Science ®Google Scholar
• Keefe RS, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, et al. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry 2007; 164: 1061–1071
   PubMed Web of Science ®Google Scholar
• Keri S, Kelemen O, Benedek G, Janka Z. Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach. Psychol Med 2001; 31: 915–922
   PubMed Web of Science ®Google Scholar
• Kim H. Assessment of memory disorders using Rey-Kim Memory test. J of Rehab Psychol 2001; 8: 29–48
   Google Scholar
• Kim Y, Oh S, Kim J, Lim Y, Hong S. Standardization study of Personality Assessment Inventory (PAI): Reliability and Validity. Korean J Clin Psychol 2001; 20: 311–329
   Google Scholar
• Krabbendam L, Marcelis M, Delespaul P, Jolles J, van Os J. Single or multiple familial cognitive risk factors in schizophrenia?. Am J Med Genet 2001; 105: 183–188
   PubMedGoogle Scholar
• Laurent A, Moreaud O, Bosson JL, Naegele B, Boucharlat J, Saoud M, et al. Neuropsychological functioning among non-psychotic siblings and parents of schizophrenic patients. Psychiatry Res 1999; 87: 147–157
   PubMed Web of Science ®Google Scholar
• Laurent A, Biloa-Tang M, Bougerol T, Duly D, Anchisi AM, Bosson JL, et al. Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives. Schizophr Res 2000; 46: 269–283
   PubMed Web of Science ®Google Scholar
• Lee MA, Jayathilake K, Meltzer HY. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophr Res 1999; 37: 1–11
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee KU, Lee DY. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. Gerontol B psychol Sci Soc Sci 2002; 57: 47–53
   PubMed Web of Science ®Google Scholar
• Morey LC. Personality Assessment Inventory Professional Manual. Psychological Assessment Resources, Odessa, FL 1991
   Google Scholar
• Mortimer AM, Joyce E, Balasubramaniam K, Choudhary PC, Saleem PT. Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia. Hum Psychopharmacol 2007; 22: 445–454
   PubMed Web of Science ®Google Scholar
• Myles-Worsley M, Coon H, McDowell J, Brenner C, Hoff M, Lind B, et al. Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families. Am J Med Genet 1999; 88: 544–550
   PubMedGoogle Scholar
• Nuechterlein KH, Dawson ME. Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 1984; 10: 160–203
   PubMed Web of Science ®Google Scholar
• Nuechterlein KH, Asarnow RF. Degraded Stimulus Continuous Performance Test (DS-CPT): Program for IBM-Compatible Micro-Computers, Version 8.12 [Computer software]. Authors, Los Angeles 1999
   Google Scholar
• Nuechterlein KH, Asarnow RF, Subotnik KL, Fogelson DL, Payne DL, Kendler KS, et al. The structure of schizotypy: relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study. Schizophr Res 2002; 54: 121–130
   PubMed Web of Science ®Google Scholar
• Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004; 72: 29–39
   PubMed Web of Science ®Google Scholar
• Rey R. L'examen psychologique dans les cas d'encéphalopathie traumatique. Archives de Psychologie 1941; 28: 286–340
   Google Scholar
• Rey R. L'examen clinique en psychologie. Press Universitaire de France, Paris 1964
   Google Scholar
• Sitskoorn MM, Aleman A, Ebisch SJ, Appels MC, Kahn RS. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res 2004; 71: 285–295
   PubMed Web of Science ®Google Scholar
• Snitz BE, Macdonald AW, 3rd, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 2006; 32: 179–194
   PubMed Web of Science ®Google Scholar
• Thompson JL, Watson JR, Steinhauer SR, Goldstein G, Pogue-Geile MF. Indicators of genetic liability to schizophrenia: a sibling study of neuropsychological performance. Schizophr Bull 2005; 31: 85–96
   PubMed Web of Science ®Google Scholar
• Trandafir A, Meary A, Schurhoff F, Leboyer M, Szoke A. Memory tests in first-degree adult relatives of schizophrenic patients: a meta-analysis. Schizophr Res 2006; 81: 217–226
   PubMed Web of Science ®Google Scholar
• Tuulio-Henriksson A, Haukka J, Partonen T, Varilo T, Paunio T, Ekelund J, et al. Heritability and number of quantitative trait loci of neurocognitive functions in families with schizophrenia. Am J Med Genet 2002; 114: 483–490
   PubMedGoogle Scholar
• Tuulio-Henriksson A, Arajarvi R, Partonen T, Haukka J, Varilo T, Schreck M, et al. Familial loading associates with impairment in visual span among healthy siblings of schizophrenia patients. Biol Psychiatry 2003; 54: 623–628
   PubMed Web of Science ®Google Scholar
• Voruganti LP, Awad AG, Parker G, Forrest C, Usmani Y, Fernando ML, et al. Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine. Schizophr Res 2007; 96: 146–155
   PubMedGoogle Scholar
• Warnick EL, Allen DN. Verbal and spatial working memory differences among individuals with familial and non-familial risk for schizophrenia. Schizophr Res 2005; 77: 361–362
   PubMedGoogle Scholar
• Woodward ND, Tibbo P, Purdon SE. An fMRI investigation of procedural learning in unaffected siblings of individuals with schizophrenia. Schizophr Res 2007; 94: 306–316
   PubMedGoogle Scholar
• Yeom Y, Park Y, Oh K, Kim J, Lee Y. K-Wechsler Adult Intelligence Scale. Korea Guidance, SeoulKorea 1992
   Google Scholar